Ironwood Pharmaceuticals | IRWD - Market Capitalization


Ironwood Pharmaceuticals reported $527.5M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Akebia Therapeutics USD 502M 75M Mar/2025
Almirall EUR 2.66B 102.29M Mar/2026
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 341M 4M Sep/2025
Ardelyx USD 1.33B 390M Sep/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Charles River Laboratories USD 10.02B 2.71B Dec/2025
Coherus Biosciences USD 94M 65M Mar/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 475M 410M Mar/2026
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Lexicon Pharmaceuticals USD 416M 2M Mar/2026
MacroGenics USD 106M 29M Sep/2025
Pacira USD 1.06B 94M Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024